Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.160
+0.030 (2.65%)
At close: Apr 2, 2026, 4:00 PM EDT
1.140
-0.020 (-1.72%)
After-hours: Apr 2, 2026, 6:49 PM EDT

Allarity Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.32----
Gross Profit
0.32----
Selling, General & Admin
6.3211.4410.039.9612.36
Research & Development
6.66.17.16.9314.2
Other Operating Expenses
-9.7-17.57-
Total Operating Expenses
12.9327.2417.1334.4626.56
Operating Income
-12.61-27.24-17.13-34.46-26.56
Interest Income
0.80.530.021.812.35
Interest Expense
-0.19-0.65-0.5-0.22-0.5
Other Non-Operating Income (Expense)
2.134.8111.132.180.92
Total Non-Operating Income (Expense)
2.754.6910.6233.772.78
Pretax Income
-11.23-24.9-11.82-17.58-26.52
Provision for Income Taxes
-0.38-0.08-1.52-0.13
Net Income
-11.23-25.15-20.42-21.05-26.65
Net Income Attributable to Preferred Dividends
--0.64-8.52-4.99-
Net Income to Common
-11.23-25.15-20.42-21.05-26.65
Shares Outstanding (Basic)
142000
Shares Outstanding (Diluted)
142000
Shares Change (YoY)
794.77%47373.83%497.35%87.14%7691.04%
EPS (Basic)
-0.78-15.65-6031.31-37121502.00-3520080.00
EPS (Diluted)
-0.78-15.65-6031.31-37121502.00-3520080.00
Shares Outstanding
16.087.30.0100
Free Cash Flow
-14.83-17.65-12.75-16.84-14.89
Free Cash Flow Per Share
-1.03-10.98-3765.14-29708.82-49159.54
Gross Margin
100.00%----
Operating Margin
-3939.06%----
Profit Margin
-3509.69%----
FCF Margin
-4633.75%----
EBITDA
-12.62-27.23-17.09-34.4-26.45
EBITDA Margin
-3943.13%----
EBIT
-12.61-27.24-17.13-34.46-26.56
EBIT Margin
-3939.06%----
Effective Tax Rate
0.00%-1.53%0.70%8.65%0.50%
Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q